(4-{[4-(1,3-Dioxolan-2-yl)-2-(methyloxy)phenyl]oxy}-2-nitrophenyl)formamide → (2-Amino-4-{[4-(1,3-dioxolan-2-yl)-2-(methyloxy)phenyl]oxy}phenyl)formamide
Reaction equation
[O:1]1[CH2:5][CH2:4][O:3][CH:2]1[C:6]1[CH:11]=[CH:10][C:9]([O:12][C:13]2[CH:18]=[CH:17][C:16]([NH:19][CH:20]=[O:21])=[C:15]([N+:22]([O-])=O)[CH:14]=2)=[C:8]([O:25][CH3:26])[CH:7]=1>C(OCC)(=O)C.[Pd]>[NH2:22][C:15]1[CH:14]=[C:13]([O:12][C:9]2[CH:10]=[CH:11][C:6]([CH:2]3[O:1][CH2:5][CH2:4][O:3]3)=[CH:7][C:8]=2[O:25][CH3:26])[CH:18]=[CH:17][C:16]=1[NH:19][CH:20]=[O:21]Participants
4
Procedure
(4-{[4-(1,3-Dioxolan-2-yl)-2-(methyloxy)phenyl]oxy}-2-nitrophenyl)formamide (430 mg) was hydrogenated in approximately 75 mL of ethyl acetate under an atmosphere of hydrogen over 100 mg of 10% Pd on carbon (wet, degussa type) for 3 days. The catalyst was filtered away and the filtrate was concentrated to give (2-amino-4-{[4-(1,3-dioxolan-2-yl)-2-(methyloxy) phenyl]oxy}phenyl)formamide, which was used without further purification. (M+1) 330.9, 1.79 min (LC/MS method B)
Workup
- filtrationThe catalyst was filtered away
- concentrationthe filtrate was concentrated
Sources & evidence
- ORD record
- ord-cbfc8e2a0cab4caf8b7270c672accb44
- Source dataset
- uspto-grants-2011_05
- Patent number
- US07939528B2
Reaction notes
Loading…